Health Care & Life Sciences » Pharmaceuticals | Huadong Medicine Co. Ltd.

Huadong Medicine Co. Ltd. A | Mutual Funds

Mutual Funds that own Huadong Medicine Co. Ltd. A

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
China AMC Advantage Growth Stock Fund
16,487,220
1.27%
14,150,226
2.93%
12/31/2017
Great Wall Brand Merit Choosed Equity Fund
8,451,974
0.65%
-1,448,026
9.96%
12/31/2017
China AMC Return Fund
6,728,304
0.52%
1,285,950
2.95%
12/31/2017
6,407,679
0.49%
-1,132,350
9.91%
12/31/2017
Neuberger Berman Invt. Funds Plc - Greater China Equity Fund
6,406,143
0.49%
250,213
3.57%
03/29/2018
Harvest Research Select Fund
5,465,187
0.42%
0
6.6%
12/31/2017
Caisse de Dépôt & Placement du Québec
4,049,460
0.31%
1,784,382
0.01%
12/31/2017
Harvest Large Cap Value Fund
3,947,016
0.3%
-1,370,850
5.28%
12/31/2017
Harvest High-quality Enterprise Equity
3,736,677
0.28%
630,600
8.97%
12/31/2017
China AMC Return II Fund
3,628,671
0.28%
607,089
3.23%
12/31/2017

About Huadong Medicine Co.

View Profile
Address
No. 866 Moganshan Road
Hangzhou Zhejiang 310011
China
Employees -
Website http://www.eastchinapharm.com
Updated 07/08/2019
Huadong Medicine Co., Ltd. engages in the production and sale of antibiotics, proprietary Chinese medicine, chemical synthetic medicine, and genetic engineering drugs. It involves in wholesale, retail, and distribution of Chinese and western medicine, Chinese herbal medicine, medical apparatus and instruments. Its products include Chinese medicine, drug immune agents, endocrine drugs, gastrointestinal agents, active pharmaceutical ingredient, hepatitis B medicine, and antineoplastic agents.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.